Advanced search
Publication Cover
Clinical Toxicology Volume 56, 2018 - Issue 5
Submit an article Journal homepage
477
Views
5
CrossRef citations to date
0
Altmetric
Poison Centre Research

Asenapine, iloperidone and lurasidone exposures in young children reported to U.S. poison centers

Gina StassinosMaryland Poison Center, Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, MD, USACorrespondence[email protected]
View further author information
&
Wendy Klein-SchwartzMaryland Poison Center, Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, MD, USAView further author information
Pages 355-359 | Received 24 May 2017, Accepted 28 Sep 2017, Published online: 10 Oct 2017

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Nicholas Husak, Thomas W. Laudone & James B. Leonard. (2023) A descriptive study of aripiprazole, brexpiprazole, and cariprazine exposures in children ages 0 to 5 years reported to United States poison centers. Clinical Toxicology 61:2, pages 110-115.
Read now
S. J. Weiss, V. A. Cueto-Vilorio, R. Dharmaraj, D. Barolia, A. Nashat, S. J. Walsh & S. E. Simpson. (2020) Characterization of intentional lurasidone ingestions using the United States National Poison Data System. Clinical Toxicology 58:12, pages 1342-1346.
Read now

Articles from other publishers (3)

Jared W. Castle, Danielle M. Butzbach, G. Stewart Walker, Claire E. Lenehan, Frank Reith, Samuel P. Costello & K. Paul Kirkbride. (2023) Microbial degradation products of lurasidone and their significance in postmortem toxicology. Drug Testing and Analysis 15:5, pages 551-565.
Crossref
Tom B. Mole, Yulia Furlong, Richard J. Clarke, Pradeep Rao, Julia K. Moore, Giulia Pace, Hugo Van Odyck & Wai Chen. (2021) Lurasidone for Adolescents With Complex Mental Disorders: A Case Series. Journal of Pharmacy Practice 35:5, pages 800-804.
Crossref
Przemysław J. Danek, Jacek Wójcikowski & Władysława A. Daniel. (2020) Asenapine and iloperidone decrease the expression of major cytochrome P450 enzymes CYP1A2 and CYP3A4 in human hepatocytes. A significance for drug-drug interactions during combined therapy. Toxicology and Applied Pharmacology 406, pages 115239.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.